Effect of citronellol and the Chinese medical herb complex on cellular immunity of cancer patients receiving chemotherapy/radiotherapy

Leukopenia and immunity impairment usually occur during cancer therapy. Citronellol, an oil soluble compound derived from the geranium, has anticancer and antiinflammatory properties, as well as promoting wound healing. Ganoderma lucidum, Codonopsis pilosula and Angelicae sinensis are traditional Ch...

Full description

Saved in:
Bibliographic Details
Published inPhytotherapy research Vol. 23; no. 6; pp. 785 - 790
Main Authors Zhuang, Shu-Ru, Chen, Su-Lin, Tsai, Jih-Hsin, Huang, Chi-Chou, Wu, Tzu-Chin, Liu, Wen-Shan, Tseng, Hsien-Chun, Lee, Hong-Sen, Huang, Min-Chang, Shane, Guang-Tzuu, Yang, Cheng-Hua, Shen, You-Cheng, Yan, Yeong-Yu, Wang, Chin-Kun
Format Journal Article
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 01.06.2009
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Leukopenia and immunity impairment usually occur during cancer therapy. Citronellol, an oil soluble compound derived from the geranium, has anticancer and antiinflammatory properties, as well as promoting wound healing. Ganoderma lucidum, Codonopsis pilosula and Angelicae sinensis are traditional Chinese herbs, all of which have proven immunomodulatory functions in laboratory-based research. This randomized, double-blind, placebo-controlled study examined whether the Chinese medicinal herb complex (CCMH; a mixture of citronellol and extracts of G. lucidum, C. pilosula and A. sinensis) improves the immune cell counts of cancer patients receiving chemotherapy and/or radiotherapy. A total of 105 cancer patients receiving chemotherapy or radiotherapy were enrolled. The quantities of immune cells in the blood of the subjects were determined before and after 6 weeks of cancer treatment, with either CCMH or a placebo. CCMH significantly reduced the depletion of leukocytes (14.2% compared with 28.2%) and neutrophils (11.0% compared with 29.1%). Analysis of the lymphocyte phenotype revealed that the patients receiving the placebo had reduced CD4 lymphocytes and natural killer (NK) cells than the CCMH-treated patients. Treatment with CCMH for patients receiving chemotherapy and/or radiotherapy may improve their immune function, improving their ability to fight off the cancer, as well as any secondary infections that could compromise their treatment and their health. Copyright © 2009 John Wiley & Sons, Ltd.
Bibliography:http://dx.doi.org/10.1002/ptr.2623
ark:/67375/WNG-C1RKDCLX-N
ArticleID:PTR2623
istex:46CCEC7CE6C150F41ADDF262936A5E8D1FE3817C
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ISSN:0951-418X
1099-1573
DOI:10.1002/ptr.2623